Use of kadambadi kasaya for management of diabeties .

Preclinical and clinical study to Determine the Safety and Efficacy of Kadambadi Kasaya in the Treatment of Madhumeha,Type 2 Diabetes mellitus. - nil

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2026/06/111705

Enrollment

Registered

2026-06-02

Start date

Unknown

Completion date

Unknown

Last updated

2026-06-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E119- Type 2 diabetes mellitus without complications

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: In order to be eligible to participate in this study, an individual must meet all of the follo criteria: -Participants should sign an informed consent form after proper understanding Subjects between the age of 30 and 70 years -Body mass index between 25 and 40 kg/m Fasting plasma glucose between 125 and 180 gm/dl and Post Prandial Blood sugar 200-300mg/dl will be included in the present study Recently diagnosed case of type-2 diabetes mellitus.less than 1 year.

Exclusion criteria

Exclusion criteria: Pregnant or planning for pregnancy, breastfeeding mother. Enrolled in other clinical trials. Have active malignancy or are under investigation for malignancy Have a history of any of the following medical conditions Cushing syndrome HIV Chronic kidney disease (CKD) Chronic liver disease Hyperthyroidism Alcohol and/or substance abuse. Currently taking any of the following medications-Psychiatric medication Anti diabetic medication Weightloss medication Oral steroids Unable to participate due to other factors

Design outcomes

Primary

Measure	Time frame
The primary objective of this study is to determine the anti-hyperglycaemic potential of Kadambadi Kasaya, an Ayurvedic polyherbal formulation consisting of containing bark of Kadamba (Anthocephalus indicus), bark of Shawl (Shorea robusta), bark of Arjuna (Terminalia arjuna), and root of Chitraka (Plumbago zeylanica).through pharmacognostic, phytochemical, experimental and clinical studies, to develop a safe and cost-effective medicine for treating prameha with special reference to type-2 diabetes mellitus by examining its anti-hyperglycemic activity.Timepoint: 4 weeks	—

Measure

Time frame

The primary objective of this study is to determine the anti-hyperglycaemic potential of Kadambadi Kasaya, an Ayurvedic polyherbal formulation consisting of containing bark of Kadamba (Anthocephalus indicus), bark of Shawl (Shorea robusta), bark of Arjuna (Terminalia arjuna), and root of Chitraka (Plumbago zeylanica).through pharmacognostic, phytochemical, experimental and clinical studies, to develop a safe and cost-effective medicine for treating prameha with special reference to type-2 diabetes mellitus by examining its anti-hyperglycemic activity.Timepoint: 4 weeks

—

Secondary

Measure	Time frame
Effect of test drug on quality of life among the patients suffering from type-2 diabetes mellitusTimepoint: 8 months	—

Countries

India

Contacts

Public ContactVishal malakar

Institiute of Post Graduate Ayurves dic Education and Research at SVSP Hospital.,

atipgaer@gmail.com9874849650

Outcome results